THC clinical trials at University of California Health
3 in progress, 2 open to eligible people
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
open to eligible people ages 21-65
This crossover study will evaluate 3 different treatments of vaporized cannabis (THC, THC/CBD mix, and CBD) and vaporized placebo cannabis for the acute treatment of migraine.
at UCSD
THC Crossover Study
open to eligible people ages 21 years and up
This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the differences in toxicant exposure and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.
at UCSF
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Sorry, not yet accepting patients
This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.
at UCSD
Our lead scientists for THC research studies include Nathaniel M Schuster, MD.
Last updated: